RDX and gastric cancer: Elevated miR-196a/-196b expression in gastric cancer reduced the expression of radixin, suggesting that miR-196a/-196b inhibitory oligonucleotides can be considered as a therapeutic potential in suppressing gastric cancer metastasis [212].